Skip to contentW
Windtree Therapeutics Inc
W
WINTWindtree Therapeutics Inc Q3 2016 · 10-Q
Revenue$961.00K$961.00K+1,356.1% vs Q3 2015 Net Income-$8.36M-$8.36MN/M vs Q3 2015 EPS Diluted-$1.00-$1.00N/M vs Q3 2015 Operating Income-$7,733,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$8,376,000N/M Margins · derivedOperating margin-804.7%+11987.7 pt vs Q3 2015
Net margin-870.2%+31790.4 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end